The standard dose of Wegovy for weight loss is 2.4mg once a week
How GLP-1s cause weight loss There are three GLP-1 agonists approved in the last few years for the treatment of obesity: tirzepatide (Zepbound), semaglutide (Wegovy), and liraglutide (Saxenda)
Some patients might also experience mild stomach pain or heartburn
In the last decade, the drugs have skyrocketed in popularity for their weight loss properties
attenuates in most patients as gastric adaptation occurs First-line management: Dietary sulfur load reduction, meal timing relative to injection day, and small-portion eating When to escalate: Persistent belching paired with regurgitation, significant dysphagia, or weight loss beyond expected therapeutic loss warrants GI evaluation When to discontinue: Sulfur burps alone are rarely grounds for stopping
We further report that LST-1 and SYGL-1 are required for the proper levels of FBF-2 and LAG-1 in germline stem cells